FDA Adverse Event Injury Summary report: N

VANGUARD SERIES A PAT THIN 37X8.6 3 PEG

MDR report key: 24498410 · Received March 3, 2026

Report

Report Number
0001825034-2026-00489
Event Type
Injury
Date Received
March 3, 2026
Date of Event
January 28, 2025
Report Date
March 3, 2026
Manufacturer
ZIMMER BIOMET, INC.
Product Code
JWH
UDI-DI
00887868344169
PMA / PMN Number
K171054
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
OK, US
Reporter Occupation
PHYSICIAN
Health Professional
Yes

Narratives

Additional Manufacturer Narrative · 0

(B)(4) D10: 183014 - VANGUARD CR ILOK FEM-RT 75 - (B)(6), 189120 - VNGD ANT STBLZD BRG 10X83 - (B)(6), 141236 - BIOMET CC CRUCIATE TRAY 83MM - (B)(6), 110035368 - BIOMET BC R 1X40 US - (B)(6), 110035368 - BIOMET BC R 1X40 US - (B)(6). CUSTOMER HAS INDICATED THAT THE PRODUCT WILL NOT BE RETURNED TO ZIMMER BIOMET FOR INVESTIGATION. ONCE THE INVESTIGATION HAS BEEN COMPLETED, A FOLLOW-UP MDR WILL BE SUBMITTED.

Description of Event or Problem · 0

IT WAS REPORTED THAT APPROXIMATELY 1 MONTH POST-OP, THE PATIENT PRESENTED WITH PAIN, SWELLING, INSTABILITY, AND INCREASING PATELLA ALTA. THE PATIENT UNDERWENT PATELLAR TENDON REPAIR DUE TO INFERIOR POLE RUPTURE. AFTERWARD, THE CERCLAGE WIRE FAILED RESULTING IN AN ADDITIONAL REPAIR WHICH AGAIN FAILED. SUBSEQUENTLY, THE PATIENT UNDERWENT A REVISION DUE TO PAIN, SWELLING, FLEXION CONTRACTURE, AND CHRONIC PATELLAR TENDON RUPTURE. DURING THE REVISION, THE INITIAL TIBIAL AND REVISED PATELLAR IMPLANTS WERE RETAINED. THE BEARING AND FEMORAL COMPONENTS WERE REVISED AND AN EXTENSOR MECHANISM ALLOGRAFT RECONSTRUCTION COMPLETED WITHOUT COMPLICATIONS. THE PATIENT DEMONSTRATED SATISFACTORY PROGRESS WITH STRENGTH AND AMBULATION WITH NO FURTHER COMPLICATIONS. ATTEMPTS HAVE BEEN MADE AND NO FURTHER INFORMATION HAS BEEN PROVIDED.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
562930 VANGUARD SERIES A PAT THIN 37X8.6 3 PEG PROSTHESIS, KNEE JWH ZIMMER BIOMET, INC. 371030 00887868344169

Patients

Seq Age Sex Outcome Treatment
1 NA Male Required Intervention| H SEE H11.